Big Health Meeting in Hyderabad in 2026

Hyderabad will host BioAsia 2026 on February 17-18. This event will bring together many global experts and companies to talk about new health technology and medicine. It's a great chance to see the latest in science.
By Newsroom | Health, Technology |

The BioAsia 2026 summit is set to convene in Hyderabad from February 17-18, 2026, with expectations of unprecedented global participation. This event aims to solidify Hyderabad's standing as a world center for life sciences, fostering collaboration and showcasing advancements across pharmaceuticals, biotechnology, medical technology, and digital health. With over 175 exhibitors and a projected 4,000 delegates, the summit signifies a substantial increase from its 2025 edition, which drew approximately 3,000 attendees. The central theme, 'TechBio Unleashed: AI, Automation & the Biology Revolution,' underscores a forward-looking approach to healthcare, emphasizing the intersection of technology and life sciences.

Summit Scale and Scope

BioAsia 2026 is slated to be the 23rd iteration of this significant global event, held at the HITEX Exhibition Centre in Hyderabad. The two-day summit, commencing on February 17, 2026, is anticipated to draw more than 4,000 delegates from around the globe. This marks a considerable upswing from the 3,000 delegates who attended in 2025, suggesting growing international interest in Hyderabad as a hub for life sciences innovation and investment. The exhibition component will feature over 175 exhibitors representing various sectors.

Read More: Andhra Pradesh and Gates Foundation to Use AI for Better Health Services

  • Pharmaceuticals and Biotechnology: Prominent global companies such as Novartis, Eli Lilly, Sanofi, MSD, and Miltenyi Biotec are expected, alongside Indian leaders like Dr. Reddy’s Laboratories and Biocon Biologics.

  • Medtech and Digital Health: These areas will also be represented, reflecting the broadening scope of healthcare innovation.

  • Advanced Manufacturing: This sector's inclusion points to an interest in the production and scaling of new therapies.

The event's venue is the HITEX Exhibition Centre, Hyderabad, with specific details placing it in Hall 4.

BioAsia 2026 to kick off on February 17 with record participation - 1

Key Themes and Technological Integration

The overarching theme for BioAsia 2026, 'TechBio Unleashed: AI, Automation & the Biology Revolution,' highlights a significant shift in the industry. This theme reflects the deep integration of technology into biological research and healthcare delivery.

  • AI in Life Sciences: Artificial intelligence is expected to play a pivotal role. Speakers like Pushmeet Kohli from Google DeepMind are scheduled to discuss how foundational AI models and protein science accelerate innovation. Dr. Howard Y Chang of Amgen will address AI-enabled biology's role in target identification and precision medicine. Anton Groom, Chief AI Officer at MSD, is also slated to participate.

  • Automation and Biology: The fusion of automation with biological processes is seen as key to transforming drug discovery, diagnostics, manufacturing, and patient care, making it more predictive, personalized, and accessible.

  • Emerging Treatment Technologies: The summit will explore areas such as synthetic biology, genomics, biomanufacturing, cell and gene therapy, mRNA technologies, and radiopharmaceuticals.

Prominent Participants and Speakers

BioAsia 2026 is attracting a distinguished roster of leaders from industry, academia, government, and regulatory bodies.

Read More: Measles Cases Rise in UK, Making People Sick

  • Industry Leaders: Key figures expected include the Chief Scientific Officer of Amgen (Dr. Howard Y Chang), Founder & President of Miltenyi Biotec (Dr. Stefan Miltenyi), Chief AI Officer of MSD (Anton Groom), Vice President of Science at Google DeepMind (Pushmeet Kohli), and executives from Sanofi, Novartis, Eli Lilly, Medtronic, and Bristol Myers Squibb.

  • Government and Academia: Union Ministers Piyush Goyal and Ashwini Vaishnaw are scheduled to attend. Ajay Kumar Sood, Principal Scientific Adviser, and Dr. Rajeev Singh Raghuvanshi, Drug Controller General of India, are also expected. Prof Bruce L Levine of the University of Pennsylvania is a keynote speaker.

  • Keynote and Special Addresses: Beyond the aforementioned speakers, the event features discussions on topics like Global Capability Centres, biologics, and gene therapies.

Strategic Objectives and Partnerships

BioAsia aims to serve as a critical platform for accelerating life sciences innovation and fostering global partnerships.

Read More: IKEA Offers New Smart Home Gadgets That Work Together Easily

  • Investment and Collaboration: The summit is designed to attract investment, facilitate strategic networking, and encourage collaborations that drive meaningful progress in healthcare.

  • Ecosystem Growth: By bringing together startups, researchers, investors, and policymakers, BioAsia seeks to strengthen the entire life sciences ecosystem.

  • Global Hub: The event's scale and the caliber of participants are intended to reinforce Hyderabad's position as a significant global hub for life sciences, research, and development.

Dates and Venue Confirmation

Official confirmations place the BioAsia 2026 summit on February 17-18, 2026. The event will be held at the HITEX Exhibition Centre in Hyderabad, specifically within Hall 4. This timeframe aligns with multiple sources, solidifying the dates for this significant international gathering.

Sources

Read More: Australia Will Soon Require Health Star Ratings on Packaged Foods

Frequently Asked Questions

Q: When is BioAsia 2026?
BioAsia 2026 will be on February 17 and 18, 2026.
Q: Where is it?
It will be at the HITEX Exhibition Centre in Hyderabad.
Q: What is the main topic?
The main topic is how AI and new technology can help with biology and health.
Q: How many people will be there?
More than 4,000 people are expected to attend.